Growing inhalable drug Market
Estimated to reach $65.4B by 2034.
20+ Years Experience
a unique DELIVERY system
The “HELIOS” inhalation system offers targeted drug delivery with the potential to reduce negative side effects.
To develop and market innovative products based on our patented technology utilizing the unique inhalation delivery dynamics of pharmaceuticals to improve treatment, outcomes, and quality of life.
The “HELIOS” series of inhalers incorporates smart technology for easy data collection of dosage, carrier gas flow and pressure, and other critical quality assurance requirements. The system is designed to provide secure data and metrics to physicians and caregivers.
Unique single dose cartridges are integral to the Heliox system and are scanned and recorded daily as part of a typical series of prescription doses for quality assurances purposes.